Documents
Federal rules and notices from the public comment record, analyzed continuously.
FDA ▾
Clinical Decision Support Software Guidance for Industry and Food and Drug Administration Staff
2 comments
Net support 0% across analyzed comments
Top issues in comments
- Patient-facing software classification
- Regulatory burden on ehr functions
Using Relative Supersaturation to Support “Urinary Tract Health” Claims for Adult Maintenance Cat Food; Guidance for Industry; #284
2 comments
Net support +100% across analyzed comments
Top issues in comments
Oral Drug Products Administered Via Enteral Feeding Tube: In Vitro Testing and Labeling Recommendations Guidance for Industry DRAFT GUIDANCE
2 comments · 2 awaiting analysis
Analysis in progress
Top issues in comments
Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products; Guidance for Industry
2 comments
Net support +100% across analyzed comments
Top issues in comments
- Real-world evidence standards
Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development; Guidance for Industry
1 comment
Net support +100% across analyzed comments
Top issues in comments
Citizen Petition from Nicholas Warack, et al.
1 comment
Net support +100% across analyzed comments
Top issues in comments
Chemistry, Manufacturing, and Controls Flexibilities for Developing Human Cellular and Gene Therapy Products for a Biologics License Application; Guidance for Industry
1 comment
Net support +100% across analyzed comments
Top issues in comments
Citizen Petition from Earthjustice, et. al.
1 comment
Net support +100% across analyzed comments
Top issues in comments
Citizen Petition from Connor Carmichael
1 comment
Net support +100% across analyzed comments
Top issues in comments
Animal Generic Drug User Fee Act; Public Meeting; Request for Comments
1 comment
Net support +100% across analyzed comments
Top issues in comments
Submitting Clinical Trial Datasets to Evaluate the Impact of Immunogenicity on the Pharmacokinetics of a Drug; Guidance for Industry
1 comment
Net support 0% across analyzed comments
Top issues in comments
Patient-Focused Drug Development for Nonhealing Chronic Wounds; Public Meeting; Request for Comments
1 comment
Net support +100% across analyzed comments
Top issues in comments
